Skip to main content
. Author manuscript; available in PMC: 2016 Jun 8.
Published in final edited form as: Cancer Cell. 2015 May 21;27(6):852–863. doi: 10.1016/j.ccell.2015.04.010

Figure 8. Combination of BDA-366 and RAD001 synergistically represses lung cancer in vivo.

Figure 8

Nu/Nu mice with H460 lung cancer xenografts were treated with BDA-366, RAD001 or their combination by i.p. for 14 days (n = 6 mice per group). Tumor volume (A), active caspase 3 in tumor tissues (B), body weight (C) and blood (D) were analyzed. Scale bar represents 10 um. Error bars represent ± S.D. See also Figure S6.